Moriah E. Weese-Myers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Moriah E. Weese-Myers has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ashley Elizabeth Ross
Department of Chemistry, University of Cincinnati, 312 College Dr. 404 Crosley Tower, Cincinnati, Ohio 45221-0172, United States
11 shared publications Colby E. Witt
University of Cincinnati, Department of Chemistry, 312 College Dr., 404 Crosley Tower, Office# 418A Rieveschl, Cincinnati, OH 45221-0172, USA
2 shared publications- Michael Thomas Cryan
Department of Chemistry, University of Cincinnati, 404 Crosley Tower, 312 College Drive, Cincinnati, Ohio 45221-0172, United States
2 shared publications Romana Jarosova
University of Cincinnati, Department of Chemistry, 312 College Dr., 404 Crosley Tower, Office# 418A Rieveschl, Cincinnati, OH 45221-0172, USA
2 shared publications- Vivek Subedi
Department of Chemistry, University of Cincinnati, 312 College Dr. 404 Crosley Tower, Cincinnati, Ohio 45221-0172, United States
2 shared publications - Yuxin Li
Department of Chemistry, Burke Laboratories, Dartmouth College, 41 College St., Hanover, New Hampshire 03755, United States
2 shared publications
Latest Publications
- Open Access
Paclitaxel Dosing Regimens Drive Differential CD4⁺ T Cell Responses in the Dorsal Root Ganglia and Modulate Neuropathic Pain Severity
While chemotherapy is effective in killing cancer cells, its non-specific cytotoxicity harms peripheral neurons, leading to chemotherapy-induced peripheral neuropathy (CIPN). Lacking effective interventions, clinicians often reduce or discontinue treatment. However, these adjustments do not necessarily reverse neuropathy and may jeopardize cancer control. Growing evidence now indicates that chemotherapy not only exerts neurotoxic effects but also modulates immune responses. The degree to which chemotherapy dosing regimens shape CD4 + T cell responses in the dorsal root ganglia (DRG), and how these cells influence mechanical hypersensitivity, remains poorly understood. In this study, female mice were administered a single, high dose (sHD) or multiple low doses (mLD) of paclitaxel (PTX). The mLD group, which received the higher cumulative dose, exhibited an earlier T cell response in the DRG and attenuated mechanical hypersensitivity with fewer ATF3 + DRG neurons compared to the sHD group. This regimen promoted a focused CD4 + T cell response while driving a broad and diversified CD8 + T cell expansion. In contrast, the sHD PTX regimen elicited a delayed, polyfunctional CD4 + T cell response but generated limited CD8 + effector differentiation. To directly assess the contribution of CD4 + T cells to CIPN pathogenesis, we administered PTX to mice lacking CD4 + T cells. CD4 deficient mice were significantly less hypersensitive than CD4 + sufficient mice with a stronger reduction in the sHD group. Although higher cumulative doses are associated with increased CIPN risk, our results suggest that the concentration and frequency of PTX more directly influence DRG immune programming, and that this immune shaping modulates CIPN severity.
Open AccessPaclitaxel Dosing Regimens Drive Differential CD4⁺ T Cell Responses in the Dorsal Root Ganglia and Modulate Neuropathic Pain Severity
While chemotherapy is effective in killing cancer cells, its non-specific cytotoxicity harms peripheral neurons, leading to chemotherapy-induced peripheral neuropathy (CIPN). Lacking effective interventions, clinicians often reduce or discontinue treatment. However, these adjustments do not necessarily reverse neuropathy and may jeopardize cancer control. Growing evidence now indicates that chemotherapy not only exerts neurotoxic effects but also modulates immune responses. The degree to which chemotherapy dosing regimens shape CD4 + T cell responses in the dorsal root ganglia (DRG), and how these cells influence mechanical hypersensitivity, remains poorly understood. In this study, female mice were administered a single, high dose (sHD) or multiple low doses (mLD) of paclitaxel (PTX). The mLD group, which received the higher cumulative dose, exhibited an earlier T cell response in the DRG and attenuated mechanical hypersensitivity with fewer ATF3 + DRG neurons compared to the sHD group. This regimen promoted a focused CD4 + T cell response while driving a broad and diversified CD8 + T cell expansion. In contrast, the sHD PTX regimen elicited a delayed, polyfunctional CD4 + T cell response but generated limited CD8 + effector differentiation. To directly assess the contribution of CD4 + T cells to CIPN pathogenesis, we administered PTX to mice lacking CD4 + T cells. CD4 deficient mice were significantly less hypersensitive than CD4 + sufficient mice with a stronger reduction in the sHD group. Although higher cumulative doses are associated with increased CIPN risk, our results suggest that the concentration and frequency of PTX more directly influence DRG immune programming, and that this immune shaping modulates CIPN severity.
- Open Access
- 20 April 2026
- Published by Springer Nature in Purinergic Signalling
- Vol. 22 (3)
Guanosine contributes to rapid purinergic regulation of dopamine during ischemia
Purinergic modulation of neurotransmission is a primary strategy employed in rapid neuroprotection during and after ischemic stroke. While the contributions of adenosine and ATP to the purinome are well-documented, guanosine-based regulatory activity has remained under-investigated. In the ischemia-vulnerable CA1 region of the hippocampus, dopamine serves as both a neurotransmitter involved in long-term potentiation during memory acquisition and as a regulator focused on modulating glutamate activity. Dopamine has been suggested as a potential protective force against glutamate-induced excitotoxicity in early ischemia. Here, we investigate changes in dopamine signaling during ischemia and demonstrate that guanosine administration during injury has an immediate protective effect. We observe rapid suppression of dopamine release following ischemic insult that is completely restored with administration of a low micromolar dose of guanosine. Changes in dopamine signaling and short-term mRNA production further suggest that guanosine’s rapid regulatory role may be partially achieved through the adenosine A1 and A2a receptors and that it facilitates dopamine reuptake through the dopamine transporter DAT. We present the first evidence that guanosine plays a rapid regulatory role in dopamine neurotransmission and that it may function as a broad facilitator of neurotransmitter reuptake, diversifying our understanding of the purinome in ischemia.
- 20 April 2026
- Published by Springer Nature in Purinergic Signalling
- Vol. 22 (3)
Open AccessGuanosine contributes to rapid purinergic regulation of dopamine during ischemia
Purinergic modulation of neurotransmission is a primary strategy employed in rapid neuroprotection during and after ischemic stroke. While the contributions of adenosine and ATP to the purinome are well-documented, guanosine-based regulatory activity has remained under-investigated. In the ischemia-vulnerable CA1 region of the hippocampus, dopamine serves as both a neurotransmitter involved in long-term potentiation during memory acquisition and as a regulator focused on modulating glutamate activity. Dopamine has been suggested as a potential protective force against glutamate-induced excitotoxicity in early ischemia. Here, we investigate changes in dopamine signaling during ischemia and demonstrate that guanosine administration during injury has an immediate protective effect. We observe rapid suppression of dopamine release following ischemic insult that is completely restored with administration of a low micromolar dose of guanosine. Changes in dopamine signaling and short-term mRNA production further suggest that guanosine’s rapid regulatory role may be partially achieved through the adenosine A1 and A2a receptors and that it facilitates dopamine reuptake through the dopamine transporter DAT. We present the first evidence that guanosine plays a rapid regulatory role in dopamine neurotransmission and that it may function as a broad facilitator of neurotransmitter reuptake, diversifying our understanding of the purinome in ischemia.
- Open Access
- 28 March 2026
- Published by American Chemical Society (ACS) in ACS Electrochemistry
- Vol. 2 (5) , 1262-1272
Optimization of Subsecond Estradiol Detection through Analysis of Surface–Analyte Interactions
Subsecond neurochemical signaling is the fastest and one of the most diverse forms of intercellular communication employed along the neuro-immune-endocrine axis; consequently, spatiotemporally resolved approaches with high sensitivity and selectivity tailored to specific analytes are required for adequate monitoring. However, many existing electrochemical approaches are optimized solely towards catecholamine and indolamine detection, leaving a wide array of structurally diverse neuroregulators at a disadvantage with limited detection capability. Here, we use estradiola fast-signaling neurosteroid vital for neuroprotection that has proven difficult to detect with existing methodsas a model target analyte for optimizing direct electrochemical detection at carbon surfaces. We take a two-pronged approach to optimizing estradiol detection by examining the electrode-analyte interface from the perspective of both the carbon surface and the target molecule. We first establish the surface characteristics of diverse carbon fibers, then examine estradiol’s electrochemical behavior at each surface. Finally, we determine the contributions of estradiol’s structure to specific adsorption, elucidating subtle structural considerations to analyte-specific tailoring of carbon electrodes. By taking this multi-perspective approach, we develop a thorough understanding of the interactions between carbon sensing surfaces and estradiol for improved sensitivity and selectivity. Moreover, our approach is applicable to other neglected neurochemicals that have proven challenging to detect. This work creates a potentially broadly applicable roadmap for customizing direct monitoring at carbon surfaces through a tailored approach to optimizing the electrode-analyte interface.
- 28 March 2026
- Published by American Chemical Society (ACS) in ACS Electrochemistry
- Vol. 2 (5) , 1262-1272
Open AccessOptimization of Subsecond Estradiol Detection through Analysis of Surface–Analyte Interactions
Subsecond neurochemical signaling is the fastest and one of the most diverse forms of intercellular communication employed along the neuro-immune-endocrine axis; consequently, spatiotemporally resolved approaches with high sensitivity and selectivity tailored to specific analytes are required for adequate monitoring. However, many existing electrochemical approaches are optimized solely towards catecholamine and indolamine detection, leaving a wide array of structurally diverse neuroregulators at a disadvantage with limited detection capability. Here, we use estradiola fast-signaling neurosteroid vital for neuroprotection that has proven difficult to detect with existing methodsas a model target analyte for optimizing direct electrochemical detection at carbon surfaces. We take a two-pronged approach to optimizing estradiol detection by examining the electrode-analyte interface from the perspective of both the carbon surface and the target molecule. We first establish the surface characteristics of diverse carbon fibers, then examine estradiol’s electrochemical behavior at each surface. Finally, we determine the contributions of estradiol’s structure to specific adsorption, elucidating subtle structural considerations to analyte-specific tailoring of carbon electrodes. By taking this multi-perspective approach, we develop a thorough understanding of the interactions between carbon sensing surfaces and estradiol for improved sensitivity and selectivity. Moreover, our approach is applicable to other neglected neurochemicals that have proven challenging to detect. This work creates a potentially broadly applicable roadmap for customizing direct monitoring at carbon surfaces through a tailored approach to optimizing the electrode-analyte interface.
- Open Access
- 4 March 2025
- Published by Elsevier in Current Opinion in Electrochemistry
- Vol. 51
Innovating carbon-based electrodes for direct neurochemical detection along the brain-immune axis
- 4 March 2025
- Published by Elsevier in Current Opinion in Electrochemistry
- Vol. 51
Open AccessInnovating carbon-based electrodes for direct neurochemical detection along the brain-immune axis
- 10 November 2024
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 413, 110321
New approach to control ischemic severity ex vivo
- 10 November 2024
- Published by Elsevier in Journal of Neuroscience Methods
- Vol. 413, 110321
New approach to control ischemic severity ex vivo
- Open Access
- 7 August 2024
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 149 (18) , 4643-4652
Plasma-treated gold microelectrodes for subsecond detection of Zn(ii) with fast-scan cyclic voltammetry
O2-plasma treated gold microelectrodes enable sensitive and selective detection of Zn(ii) with high spatiotemporal resolution.
- 7 August 2024
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 149 (18) , 4643-4652
Open AccessPlasma-treated gold microelectrodes for subsecond detection of Zn(ii) with fast-scan cyclic voltammetry
O2-plasma treated gold microelectrodes enable sensitive and selective detection of Zn(ii) with high spatiotemporal resolution.
- 16 December 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (1) , 76-84
Subsecond Codetection of Dopamine and Estradiol at a Modified Sharkfin Waveform
17β-Estradiol (E2) is a ubiquitously expressed hormone that is active in a wide range of neuroprotective and regenerative roles throughout the brain. In particular, it is a well-known dopamine (DA) regulator and is responsible for modulating the expression of dopaminergic receptors and transporters. Recent studies point to E2 release occurring on a rapid time scale and having impacts on DA activity within seconds to minutes. As such, tools capable of monitoring the release of both E2 and DA in real time are essential for developing an accurate understanding of their interactive roles in neurotransmission and regulation. Currently, no analytical techniques capable of codetection of both analytes with high sensitivity, spatiotemporal resolution, extended monitoring, and minimal tissue damage exist. We describe a modified waveform using fast-scan cyclic voltammetry that is capable of low nanomolar detection of both DA and E2 on a subsecond time scale. Both analytes have limits of detection at or below 30 nM and high sensitivity: 11.31 ± 0.55 nA/μM for DA and 9.47 ± 0.36 nA/μM for E2. The waveform is validated in a tissue matrix, confirming its viability for measurement in a biologically relevant setting. This is the first method capable of codetection of fluctuations in DA and E2 with the temporal, spatial, and sensitivity requirements necessary for studying real-time neurochemical signaling.
- 16 December 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (1) , 76-84
Subsecond Codetection of Dopamine and Estradiol at a Modified Sharkfin Waveform
17β-Estradiol (E2) is a ubiquitously expressed hormone that is active in a wide range of neuroprotective and regenerative roles throughout the brain. In particular, it is a well-known dopamine (DA) regulator and is responsible for modulating the expression of dopaminergic receptors and transporters. Recent studies point to E2 release occurring on a rapid time scale and having impacts on DA activity within seconds to minutes. As such, tools capable of monitoring the release of both E2 and DA in real time are essential for developing an accurate understanding of their interactive roles in neurotransmission and regulation. Currently, no analytical techniques capable of codetection of both analytes with high sensitivity, spatiotemporal resolution, extended monitoring, and minimal tissue damage exist. We describe a modified waveform using fast-scan cyclic voltammetry that is capable of low nanomolar detection of both DA and E2 on a subsecond time scale. Both analytes have limits of detection at or below 30 nM and high sensitivity: 11.31 ± 0.55 nA/μM for DA and 9.47 ± 0.36 nA/μM for E2. The waveform is validated in a tissue matrix, confirming its viability for measurement in a biologically relevant setting. This is the first method capable of codetection of fluctuations in DA and E2 with the temporal, spatial, and sensitivity requirements necessary for studying real-time neurochemical signaling.
- Open Access
- 2 June 2023
- Published by Wiley in Electroanalysis
- Vol. 35 (9)
Electrochemical characterization of 17β‐estradiol with fast‐scan cyclic voltammetry
We have developed a sensitive and stable electrochemical method for 17β‐estradiol (E2) detection using fast‐scan cyclic voltammetry (FSCV). Recently, E2 was proposed to function as a rapid synaptocrine signaling molecule in the brain; however, methods to directly monitor subsecond fluctuations in E2 are currently unavailable, limiting our understanding of the dynamics and mechanism of rapid E2 release. FSCV at carbon‐fiber microelectrodes enables subsecond detection of electroactive neurochemicals directly in tissues like the brain. Here, we have electrochemically characterized E2 using FSCV for use in a tissue matrix. The limit of detection of E2 is 31.2±2.5 nM with FSCV, which will enable low nanomolar fluctuations in extracellular E2 to be monitored with hundred millisecond temporal resolution. We also identify specific parameters for waveform modification to improve future detection. This method will significantly improve E2 sensing capabilities and will have far‐reaching impacts on improving our understanding of dynamic E2 signaling in the brain.
- 2 June 2023
- Published by Wiley in Electroanalysis
- Vol. 35 (9)
Open AccessElectrochemical characterization of 17β‐estradiol with fast‐scan cyclic voltammetry
We have developed a sensitive and stable electrochemical method for 17β‐estradiol (E2) detection using fast‐scan cyclic voltammetry (FSCV). Recently, E2 was proposed to function as a rapid synaptocrine signaling molecule in the brain; however, methods to directly monitor subsecond fluctuations in E2 are currently unavailable, limiting our understanding of the dynamics and mechanism of rapid E2 release. FSCV at carbon‐fiber microelectrodes enables subsecond detection of electroactive neurochemicals directly in tissues like the brain. Here, we have electrochemically characterized E2 using FSCV for use in a tissue matrix. The limit of detection of E2 is 31.2±2.5 nM with FSCV, which will enable low nanomolar fluctuations in extracellular E2 to be monitored with hundred millisecond temporal resolution. We also identify specific parameters for waveform modification to improve future detection. This method will significantly improve E2 sensing capabilities and will have far‐reaching impacts on improving our understanding of dynamic E2 signaling in the brain.
- 11 April 2023
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 14 (9) , 1646-1658
Dynamic and Rapid Detection of Guanosine during Ischemia
Guanosine acts in both neuroprotective and neurosignaling pathways in the central nervous system; in this paper, we present the first fast voltammetric measurements of endogenous guanosine release during pre- and post-ischemic conditions. We discuss the metric of our measurements via analysis of event concentration, duration, and interevent time of rapid guanosine release. We observe changes across all three metrics from our normoxic to ischemic conditions. Pharmacological studies were performed to confirm that guanosine release is a calcium-dependent process and that the signaling observed is purinergic. Finally, we show the validity of our ischemic model via staining and fluorescent imaging. Overall, this paper sets the tone for rapid monitoring of guanosine and provides a platform to investigate the extent to which guanosine accumulates at the site of brain injury, i.e., ischemia.
- 11 April 2023
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 14 (9) , 1646-1658
Dynamic and Rapid Detection of Guanosine during Ischemia
Guanosine acts in both neuroprotective and neurosignaling pathways in the central nervous system; in this paper, we present the first fast voltammetric measurements of endogenous guanosine release during pre- and post-ischemic conditions. We discuss the metric of our measurements via analysis of event concentration, duration, and interevent time of rapid guanosine release. We observe changes across all three metrics from our normoxic to ischemic conditions. Pharmacological studies were performed to confirm that guanosine release is a calcium-dependent process and that the signaling observed is purinergic. Finally, we show the validity of our ischemic model via staining and fluorescent imaging. Overall, this paper sets the tone for rapid monitoring of guanosine and provides a platform to investigate the extent to which guanosine accumulates at the site of brain injury, i.e., ischemia.
- 11 March 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (11) , 4803-4812
Graphene-Fiber Microelectrodes for Ultrasensitive Neurochemical Detection
Here, we have synthesized and characterized graphene-fiber microelectrodes (GFME’s) for subsecond detection of neurochemicals with fast-scan cyclic voltammetry (FSCV) for the first time. GFME’s exhibited extraordinary properties including faster electron transfer kinetics, significantly improved sensitivity, and ease of tunability that we anticipate will have major impacts on neurochemical detection for years to come. GF’s have been used in the literature for various applications; however, scaling their size down to microelectrodes and implementing them as neurochemical microsensors is significantly less developed. The GF’s developed in this paper were on average 20–30 μm in diameter and both graphene oxide (GO) and reduced graphene oxide (rGO) fibers were characterized with FSCV. Neat GF’s were synthesized using a one-step dimension-confined hydrothermal strategy. FSCV detection has traditionally used carbon-fiber microelectrodes (CFME’s) and more recently carbon nanotube fiber electrodes; however, uniform functionalization and direct control of the 3D surface structure of these materials remain limited. The expansion to GFME’s will certainly open new avenues for fine-tuning the electrode surface for specific electrochemical detection. When comparing to traditional CFME’s, our GFME’s exhibited significant increases in electron transfer, redox cycling, fouling resistance, higher sensitivity, and frequency independent behavior which demonstrates their incredible utility as biological sensors.
- 11 March 2022
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 94 (11) , 4803-4812
Graphene-Fiber Microelectrodes for Ultrasensitive Neurochemical Detection
Here, we have synthesized and characterized graphene-fiber microelectrodes (GFME’s) for subsecond detection of neurochemicals with fast-scan cyclic voltammetry (FSCV) for the first time. GFME’s exhibited extraordinary properties including faster electron transfer kinetics, significantly improved sensitivity, and ease of tunability that we anticipate will have major impacts on neurochemical detection for years to come. GF’s have been used in the literature for various applications; however, scaling their size down to microelectrodes and implementing them as neurochemical microsensors is significantly less developed. The GF’s developed in this paper were on average 20–30 μm in diameter and both graphene oxide (GO) and reduced graphene oxide (rGO) fibers were characterized with FSCV. Neat GF’s were synthesized using a one-step dimension-confined hydrothermal strategy. FSCV detection has traditionally used carbon-fiber microelectrodes (CFME’s) and more recently carbon nanotube fiber electrodes; however, uniform functionalization and direct control of the 3D surface structure of these materials remain limited. The expansion to GFME’s will certainly open new avenues for fine-tuning the electrode surface for specific electrochemical detection. When comparing to traditional CFME’s, our GFME’s exhibited significant increases in electron transfer, redox cycling, fouling resistance, higher sensitivity, and frequency independent behavior which demonstrates their incredible utility as biological sensors.